Funding for this research was provided by:
Received: 14 September 2017
Accepted: 19 January 2018
First Online: 27 January 2018
Ethics approval and consent to participate
: Ethical approval was obtained to construct and evaluate a quality of life scale for severe asthma, details: REC ref.: 16/NE/0188; IRAS ID: 207,601. The research was sponsored by Plymouth Hospitals NHS Trust. All patients gave written informed consent.
: Not applicable
: Author MH has received personal fees from Novartis and GSK. Author RJ reports personal fees from GSK, AstraZeneca, Boehringer-Ingelheim, Chiesi, Cipla, Novartis and Pfizer, and research grants from Astra Zeneca. Author MM reports personal fees from Novartis and GSK and grants from Astrazenca. Authors JL reports he has no competing interests. Author JP reports she has no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.